|
|
Volumn 9, Issue 3, 2000, Pages 253-255
|
|
We need a postmarketing drug development process!
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVERSE DRUG REACTION;
CLINICAL TRIAL;
COHORT ANALYSIS;
DRUG RESEARCH;
FOLLOW UP;
GOOD CLINICAL PRACTICE;
GOOD LABORATORY PRACTICE;
GOOD MANUFACTURING PRACTICE;
HUMAN;
MEDICAL ETHICS;
NOTE;
PHARMACOEPIDEMIOLOGY;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
|
|
EID: 0033911030
PISSN: 10538569
EISSN: None
Source Type: Journal
DOI: 10.1002/1099-1557(200005/06)9:3<253::AID-PDS522>3.0.CO;2-4 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|